OXiGENE (OXGN) Announces Updated Time For Presentation At The ROTH Conference
3/12/2014 9:02:16 AM
SOUTH SAN FRANCISCO, Calif., March 11, 2014 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, announced that the company's presentation and webcast at the ROTH Capital Partners 26th Annual Growth Stock Conference will take place on Wednesday, March 12 at 9:30 a.m. PT at The Ritz Carlton Hotel in Dana Point California. Peter Langecker, M.D., PhD., Chief Executive Officer, will provide an update and corporate overview.
Help employers find you! Check out all the jobs and post your resume.
comments powered by